Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Zenabis Global Inc. T.ZENA

We are a diverse, passionate team of doctors, scientists, researchers, growers, educators, and advocates who came together with the goal of increasing access to safe, high quality cannabis for medical patients and recreational consumers. Our four facilities are located coast-to-coast across Canada in Delta and Langley, British Columbia; Atholville, New Brunswick; and Stellarton, Nova Scotia... see more

TSX:ZENA - Post Discussion

Zenabis Global Inc. > I would buy ZENA instead
View:
Post by Jimmy713 on Mar 12, 2021 8:48pm

I would buy ZENA instead

Should You Buy HEXO (TSX:HEXO) Ahead of its 2nd-Quarter Earnings?

The cannabis space has witnessed strong buying this year with the benchmark index Horizons Marijuana Life Sciences Index ETF trading 67.6% higher for this year. With Democrats taking control of both Senate and House, investors are hopeful of pro-cannabis bills becoming laws soon. Further, the expansion of addressable markets due to increased legalization has also contributed to the strong buying.

Amid the renewed investors’ optimism, Hexo (TSX:HEXO) (NYSE:HEXO) is up 101.9% this year. Last month, it had announced an agreement to acquire Zenabis Global for $235 million in an all-stock deal, which boosted its stock price. Meanwhile, the company will post its second-quarter earnings of fiscal 2021 before the market opens on March 18. So, should you buy HEXO ahead of its earnings? Let’s first look at analysts’ expectations and the company’s growth prospects.

Second-quarter expectations

HEXO had delivered an impressive first-quarter performance in December, with its top line growing by 103% on a year-over-year basis. Its adjusted EBITDA losses declined for the sixth consecutive quarter. At the end of the first quarter, its working capital stood at $250.3 million, including $149.8 million of cash. So, the company’s financial position looks healthy.

Meanwhile, analysts are projecting the upward trend to continue in the second quarter as well. The company’s second-quarter revenue could come at $32.44 million, representing year-over-year growth of 90.8% and sequential growth of 10.1%. The relaunch of its UP brand products with higher THC content and strengthening its market share in the cannabis-infused beverage and vape segments could drive its top line in the second quarter.

Further, analysts are also hopeful that its adjusted EBITDA could improve for the seventh consecutive quarter. The company has taken several cost-cutting initiatives over the last few quarters, which, along with higher sales, could boost the company’s adjusted EBITDA in the second quarter.

Outlook

With many countries warming up towards cannabis, the sector offers strong growth prospects. Meanwhile, Research and Markets project the global cannabis market to reach $90.4 billion by 2026, representing a CAGR of 28%. Meanwhile, HEXO is taking several initiatives to capture this growing cannabis market.

HEXO plans to acquire Zenabis Global, which would position the company as one of the top three players in the Canadian recreational market. The acquisition also provides HEXO access to the European medical cannabis market. Also, the combined entity could realize around $20 million of annual synergies within one year of completing the transactions.

Further, the company’s partnership with Molson Coors Beverage provides an excellent opportunity to expand its footprint in the growing U.S. cannabis market. So, I believe HEXO’s growth prospects look healthy.

Analysts’ recommendations and bottom line

Meanwhile, analysts look less bullish on HEXO. Of the 15 analysts covering the company, 12 have issued a “hold” rating, while two analysts have given a “sell” rating, and the remaining one analyst has given a “buy” rating. Currently, analysts’ consensus price target stands at $7.63, representing a potential fall of around 19% from its current stock price.

Despite its recent surge, HEXO still trades at a cheaper valuation than its peers. The company’s price-to-book multiple currently stands at 2.1, while Canopy Growth and Aphria trade at 4.1 and 4.2, respectively. So, given its healthy growth prospects and attractive valuation, I am bullish on HEXO . I also expect HEXO to outperform analysts’ expectations in its second quarter.

The post Should You Buy HEXO (TSX:HEXO) Ahead of its 2nd-Quarter Earnings? appeared first on The Motley Fool Canada .

The Motley Fool recommends HEXO. and HEXO. Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned.

The Motley Fool’s purpose is to help the world invest, better.

Click here now for your free subscription to Take Stock , The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2021
News Provided by QuoteMedia.
Comment by quinlash on Mar 12, 2021 8:53pm
Both boards of directors are in approval of the deal so odds are it will go through.  I started my position on Zena in order to get shares of HEXO later on at a discounted price.  If my main holdings for Cannabis were with Zena... I would up the position in Zena, especially if the current shareprice were over my average. Have a great weekend Q
Comment by quinlash on Mar 12, 2021 8:54pm
meant to say under my current average..
Comment by mydogchach on Mar 12, 2021 11:17pm
why do you think anybody cares either way - something serioulsy wrong with you quinlash - (3/12/2021 8:54:49 PM) RE:RE:I would buy ZENA instead meant to say under my current average.. quinlash wrote:Both boards of directors are in approval of the deal so odds are it will go through.  I started my position on Zena in order to get shares of HEXO later on at a discounted ...more  
Comment by Papermaker61 on Mar 13, 2021 8:29am
Good point. Others are starting to think the same as Zena is up 7.41% while Hexo down 1.27% at yesterday's close.
Comment by Jimmy713 on Mar 13, 2021 8:51am
Exactly right Buying Zena at 14.5 cents would be buying Hexo at $8.18 when it closed at $9.31 that is a good junk of money. Yet with all what is expected by Hexo, it will be trading at $13ish which is minimum to Zena at 23+ cents. Not bad for 6 months or so investment!
Comment by truthseeker1 on Mar 13, 2021 11:10am
right now assuming the zena deal will pass buying zena makes more sense than buying hexo 
Comment by truthseeker1 on Mar 13, 2021 11:13am
because no matter what u pay for zena be it 13 cents or 25 cents  assuming same amount of shares  you get the same in hexo shares   10000 X.01772  =   # of hexo  shares
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities